Gráfica de Acción Histórica
3 Meses : De Dic 2018 a Mar 2019
By Adria Calatayud
GlaxoSmithKline PLC (GSK.LN) said Monday that Chairman Philip Hampton intends to step down after nearly four years in the role.
The board of the FTSE 100 pharmaceutical company has started the process to find a successor, it said.
"Following the announcement of our deal with Pfizer and the intended separation of the new consumer business, I believe this is the right moment to step down and allow a new Chair to oversee this process through to its conclusion over the next few years and to lead the Board into this next phase for GSK," Mr. Hampton said.
Mr. Hampton joined GlaxoSmithKline's board on Jan. 1 2015 and became chairman on May 7, 2015.
Write to Adria Calatayud at email@example.com
(END) Dow Jones Newswires
January 21, 2019 02:24 ET (07:24 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.